|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Oral contraceptives: a review of the literature. |
| Journal of Nurse-Midwifery 20(1): 7-14. Spring 1975. |
| After exploring the possible mechanism of action of oral contraceptives through an estrogen progestin combination, |
| as well as by means of the sequential method, the pathophysiologic and side effects of the pill, as it appears in the |
| literature, is explored in depth. Thromboembolitic disease is the only condition in which there is a definite |
| association with the use of oral contraceptive pill, and there is some doubt as to how strong the association really is. |
| Some studies suggest that mortality from thromboembolic disorders which can be attributed to the pill is about |
| 3/100,000 per year. Studies have also shown that mortality trends from thromboembolitic disease among women of |
| childbearing ages were parallel to the increased use of oral contraceptives among this group of women, however the |
| data may be weak. Data from various sources indicate that the estrogenic component of the pill are primarily |
| responsible for the thrombogenic effect, with estrogen increasing platelet adhesiveness and enhancing |
| coagulability. Progestogens, on the other hand, enhance fibroinolysis and do not alter platelet function or |
| coagulation. Other side effects of the pill such as naseau, headaches, and weight gain are usually not of any |
| serious consequence. According to 1 study, amenorrhea after cessation of the pill has occurred in very small |
| numbers, but 98% of the women are ovulatory within 3 months after cessation of the pill. The oral contraceptive pill |
| may actually have beneficial effects on genital and endometrial cancer due to the pill's progesterone content. |
| Estrogens have shown both a positive and negative influence on cancer of the uterus and breast, depending on the |
| menopausal status of the women. It is generally agreed that the best dosage of hormones in the pill is the lowest |
| possible varying with the size and body weight of the woman, among other factors. Some studies have shown that in |
| Puerto Rico, IUD users have a higher continuation rate than characteristics than the pill users, thereby making the 2 |
| groups incomparable. (PubHealth.info Document ID: CONT7T 3004-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Oral contraceptives: a review of the literature.", is(are) |
| Swenson I. The source of this article is "Journal of Nurse-Midwifery 20(1): 7-14. Spring 1975.". This article was |
| published in 1975 in English language(s). (PubHealth.info® Document ID: CONT7T 3004-06. All rights reserved with |
| PubHealth.info) PIN: 33004 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |